企業プロフィール

Leap Therapeutics 株価・ニュース・カタリスト

ティッカー:: LPTX
取引所:: NASDAQ
セクター:: Biopharma
所在地:: United States

株価変動の要因

Current closing-price context is not available for LPTX.

企業概要

事業概要

Leap Therapeutics is an oncology company focused on targeted therapies and tumor biology. Its platform is aimed at differentiated cancer mechanisms, especially in solid tumors.

所在地とセクター分類

Headquartered in the United States and listed on NASDAQ, Leap sits in specialty oncology biotechnology.

ビジネスモデルの特徴

The business depends on clinical data, target differentiation, and the ability to build a durable cancer story.

バイオ業界での位置付け

Leap is a small-cap oncology catalyst name whose stock reacts to early readouts and program progress.

今後のカタリスト

Leap’s catalysts are sirexatamab / oncology pipeline updates and any strategic step that clarifies how much value the company still has. The market wants a cleaner path.